MYD88 and B-cell chronic lymphocytic leukemia: A study by Fabbri et al. (2013) described genetic alterations in MYD88 in RS but highlighted that these alterations were already present at the CLL stage for the same patients, indicating that it is an early event in the progression of the disease [42].